| Coronary thrombolysis: progress and promise. | |
| | |
MedLine Citation:
|
PMID: 6084148 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The therapeutic history of thrombolysis in coronary heart disease is relatively recent, but is now stimulating rapidly increasing interest. Studies of the evolution of acute coronary thrombosis demonstrate the urgent necessity to commence thrombolysis treatment at the earliest possible moment. The development of newer specific thrombolytic agents with low toxicity, without antigenicity, and available for rapid parenteral administration holds much promise for the treatment of acute myocardial infarction in the future. |
| | |
Authors:
|
B E Sobel |
Related Documents
:
|
9604968 - Impact of injection rate on the thrombolysis in myocardial infarction (timi) trial fram... 11322908 - Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral... 14752128 - Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in ac... 16721208 - Electrocardiographic abnormalities mimicking myocardial infarction in a patient with in... 9415008 - Right ventricular dysfunction during coronary artery occlusion: pressure-volume analysi... 16520048 - Impact of avoiding cardiopulmonary bypass for coronary surgery on perioperative cardiac... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 6 Suppl 6 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 1984 |
Date Detail:
|
Created Date: 1985-03-18 Completed Date: 1985-03-18 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: S910-3 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Coronary Disease
/
drug therapy*,
physiopathology Fibrinolytic Agents / adverse effects, therapeutic use* Humans Peptide Hydrolases / therapeutic use Streptokinase / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Peptide Hydrolases; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Arrhythmias associated with reperfusion: basic insights and clinical relevance.
Next Document: Secondary prevention after myocardial infarction: facts and fallacies.